Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
JAMA Network Open|December 29, 2021
Association of Posttraumatic Epilepsy With 1-Year Outcomes After Traumatic Brain InjuryJohn Burke, James Gugger, Kan Ding, et al.Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.Journal of Medicinal Chemistry|January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacyDeborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.Journal of Neurotrauma|August 5, 2025
Association Between Acute Plasma Glial Fibrillary Acidic Protein Levels and White Matter Integrity in Recent Trauma SurvivorsMegan E Huibregtse, Tianyi Li, Nathaniel G Harnett, et al.Journal of Neuroinflammation|May 29, 2026
Inflammatory blood-based biomarkers to aid in the assessment and prognostication of traumatic brain injury: a TRACK-TBI studyJohn K Yue, Allen Y Fu, Sonia Jain, et al.JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.Anesthesiology|November 10, 2025
Paravertebral or serratus anterior plane block combined with PECS I (interpectoral) blocks versus paravertebral block for mastectomy: A cluster-randomized trial of 1507 patientsHanae K Tokita, Melissa J Assel, Joanna Serafin, et al.Journal of Medicinal Chemistry|October 25, 2008
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's diseaseXiaohu Zhang, John E Tellew, Zhiyong Luo, et al.Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.Journal of Medicinal Chemistry|January 15, 2009
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacyMarion C Lanier, Manisha Moorjani, Zhiyong Luo, et al.Pageof 18